Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  



























Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Mechanism  



1.1  Earlier stages  





1.2  Initiation  





1.3  Ribosome assembly  





1.4  Aminoacyl tRNA entry  





1.5  Proofreading  





1.6  Peptidyl transfer  





1.7  Ribosomal translocation  





1.8  Termination  





1.9  Protein synthesis inhibitors of unspecified mechanism  







2 Binding site  





3 See also  





4 References  














Protein synthesis inhibitor






العربية
فارسی
Bahasa Melayu
Português
Српски / srpski
Srpskohrvatski / српскохрватски



 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 


















From Wikipedia, the free encyclopedia
 


Simplified schematic of mRNA translation

Aprotein synthesis inhibitor is a compound that stops or slows the growth or proliferation of cells by disrupting the processes that lead directly to the generation of new proteins.[1]

Aribosome is a biological machine that utilizes protein dynamicsonnanoscalestotranslate RNA into proteins

While a broad interpretation of this definition could be used to describe nearly any compound depending on concentration, in practice, it usually refers to compounds that act at the molecular level on translational machinery (either the ribosome itself or the translation factor),[2] taking advantages of the major differences between prokaryotic and eukaryotic ribosome structures.[citation needed]

Mechanism[edit]

In general, protein synthesis inhibitors work at different stages of bacterial mRNA translation into proteins, like initiation, elongation (including aminoacyl tRNA entry, proofreading, peptidyl transfer, and bacterial translocation) and termination:

Earlier stages[edit]

Initiation[edit]

Ribosome assembly[edit]

Aminoacyl tRNA entry[edit]

Proofreading[edit]

Peptidyl transfer[edit]

Ribosomal translocation[edit]

Termination[edit]

Protein synthesis inhibitors of unspecified mechanism[edit]

Binding site[edit]

The following antibiotics bind to the 30S subunit of the ribosome:

The following antibiotics bind to the 50S ribosomal subunit:

See also[edit]

References[edit]

  1. ^ Frank Lowy. "Protein Synthesis Inhibitors" (PDF). Columbia University. Retrieved 2021-01-27.
  • ^ "7.344 Antibiotics, Toxins, and Protein Engineering, Spring 2007". MIT OpenCourseWare.
  • ^ Swaney SM, Aoki H, Ganoza MC, Shinabarger DL (December 1998). "The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in Bacteria". Antimicrob. Agents Chemother. 42 (12): 3251–3255. doi:10.1128/AAC.42.12.3251. PMC 106030. PMID 9835522.
  • ^ Skripkin E, McConnell TS, DeVito J, et al. (October 2008). "Rχ-01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance". Antimicrobial Agents and Chemotherapy. 52 (10): 3550–3557. doi:10.1128/AAC.01193-07. PMC 2565890. PMID 18663023.
  • ^ Mehta, Roopal; Champney, W. Scott (2003). "Neomycin and Paromomycin Inhibit 30S Ribosomal Subunit Assembly in Staphylococcus aureus". Current Microbiology. 47 (3): 237–43. doi:10.1007/s00284-002-3945-9. PMID 14570276. S2CID 23170091.
  • ^ Slover CM, Rodvold KA, Danziger LH (June 2007). "Tigecycline: a novel broad-spectrum antimicrobial". Ann Pharmacother. 41 (6): 965–972. doi:10.1345/aph.1H543. PMID 17519296. S2CID 5686856. Retrieved 2009-12-19.
  • ^ a b Flavio Guzmán (2008-08-12). "Protein synthesis inhibitors: aminoglycosides mechanism of action animation. Classification of agents". Pharmamotion. Archived from the original on 2010-03-12.
  • ^ a b Protein synthesis inhibitors: macrolides mechanism of action animation. Classification of agents Pharmamotion. Author: Gary Kaiser. The Community College of Baltimore County. Retrieved on July 31, 2009
  • ^ a b c Page 212 in: Title: Hugo and Russell's pharmaceutical microbiology Authors: William Barry Hugo, Stephen P. Denyer, Norman A. Hodges, Sean P. Gorman Edition: 7, illustrated Publisher: Wiley-Blackwell, 2004 ISBN 0-632-06467-6 Length: 481 pages
  • ^ "Geneticin". Thermo Fisher Scientific.
  • ^ Shifrin, Victor I.; Anderson, Paul (1999). "Trichothecene Mycotoxins Trigger a Ribotoxic Stress Response That Activates c-Jun N-terminal Kinase and p38 Mitogen-activated Protein Kinase and Induces Apoptosis". Journal of Biological Chemistry. 274 (20): 13985–13992. doi:10.1074/jbc.274.20.13985. ISSN 0021-9258. PMID 10318810.
  • ^ Wisteria Lane cases → CLINDAMYCIN Archived 2012-07-18 at archive.today University of Michigan. Retrieved on July 31, 2009
  • ^ Leonard JE, Grothaus CD, Taetle R (October 1988). "Ricin binding and protein synthesis inhibition in human hematopoietic cell lines". Blood. 72 (4): 1357–1363. doi:10.1182/blood.V72.4.1357.1357. PMID 3167211.
  • ^ Terao K, Uchiumi T, Endo Y, Ogata K (June 1988). "Ricin and alpha-sarcin alter the conformation of 60S ribosomal subunits at neighboring but different sites". Eur. J. Biochem. 174 (3): 459–463. doi:10.1111/j.1432-1033.1988.tb14120.x. PMID 3391162.
  • ^ a b Menninger JR (1995). "Mechanism of inhibition of protein synthesis by macrolide and lincosamide antibiotics". J Basic Clin Physiol Pharmacol. 6 (3–4): 229–250. doi:10.1515/JBCPP.1995.6.3-4.229. PMID 8852269. S2CID 36166592.
  • ^ a b Tenson T, Lovmar M, Ehrenberg M (July 2003). "The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome". J. Mol. Biol. 330 (5): 1005–1014. doi:10.1016/S0022-2836(03)00662-4. PMID 12860123.
  • ^ a b c d e f g h i Levinson, Warren (2008). Review of medical microbiology and immunology. New York: McGraw-Hill Medical. ISBN 978-0-07-149620-9.
  • ^ a b Drugbank.ca > Showing drug card for Retapamulin (DB01256) Update Date: 2009-06-23

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Protein_synthesis_inhibitor&oldid=1220760895"

    Categories: 
    Protein biosynthesis
    Protein synthesis inhibitor antibiotics
    Protein synthesis inhibitors
    Hidden categories: 
    Webarchive template archiveis links
    Articles with short description
    Short description is different from Wikidata
    All articles with unsourced statements
    Articles with unsourced statements from March 2019
    Articles with unsourced statements from March 2023
     



    This page was last edited on 25 April 2024, at 19:19 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki